Exclusion of Older Persons From Vaccine, Treatment Trials for COVID-19

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 28, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.5084?guestAccessKey=a4bf6abb-399e-4bbf-b56f-1acffd88fed1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092820

 

What The Study Did: The likelihood of older adults being excluded in randomized clinical trials for COVID-19 treatment and vaccine interventions is evaluated in this study.

Authors: Sharon K. Inouye, M.D., M.P.H., of Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School in Boston, is the corresponding author.

 

(doi:10.1001/jamainternmed.2020.5084)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.